News
The stroke market is experiencing unprecedented growth, fueled by intense corporate investment and disruptive technologies ...
Longing for the past? You’re not alone, and chances are, the place you’re missing is by the water. A new study found that ...
A panelist discusses how ASCO 2025's most important breakthrough was the oral decitabine plus venetoclax combination, representing a potential paradigm shift if approved by the FDA, while highlighting ...
Nearly half of surveyed cancer patients receiving radiation therapy expressed interest in psychedelic-assisted therapy, with ...
20h
Clinical Trials Arena on MSNSarepta refuses to pull gene therapy despite FDA request
Sarepta Therapeutics is refusing to pull its gene therapy Elevidys (delandistrogene moxeparvovec), despite a request from the FDA.
Business was booming for Swiss pharma giant Novartis in the second quarter of 2025 with 11% net sales growth riding strong ...
Solid Biosciences' DMD gene therapy shows promise with SGT-003 and strong cash backing through 2027. Click here to read an ...
Angel PAWS drove 270 miles to the Salvation Army in Kerrville. The therapy dogs quickly became a source of comfort for both ...
Müller produces her own tracks using professional-grade production software, layering frequencies to create deep neurological effects.
Overview of Plasma Therapy MarketThe global Plasma Therapy Market is valued at USD 354.33 Billion in 2024 and is projected to reach a value of USD 1575 Billion by 2035 at a CAGR (Compound Annual ...
ATLAS trial investigator Guy Young, MD, Children's Hospital Los Angeles and University of Southern California Keck School of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results